Matches in Wikidata for { <http://www.wikidata.org/entity/Q107973198> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q107973198 description "clinical trial" @default.
- Q107973198 description "ensayo clínico" @default.
- Q107973198 description "ensayu clínicu" @default.
- Q107973198 description "klinisch onderzoek" @default.
- Q107973198 description "клінічне випробування" @default.
- Q107973198 description "临床试验" @default.
- Q107973198 name "Study of Efficacy and Safety of Dabrafenib Plus Trametinib in Previously Treated Patients With Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E Mutation-positive Differentiated Thyroid Cancer" @default.
- Q107973198 name "Study of Efficacy and Safety of Dabrafenib Plus Trametinib in Previously Treated Patients With Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E Mutation-positive Differentiated Thyroid Cancer" @default.
- Q107973198 type Item @default.
- Q107973198 label "Study of Efficacy and Safety of Dabrafenib Plus Trametinib in Previously Treated Patients With Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E Mutation-positive Differentiated Thyroid Cancer" @default.
- Q107973198 label "Study of Efficacy and Safety of Dabrafenib Plus Trametinib in Previously Treated Patients With Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E Mutation-positive Differentiated Thyroid Cancer" @default.
- Q107973198 prefLabel "Study of Efficacy and Safety of Dabrafenib Plus Trametinib in Previously Treated Patients With Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E Mutation-positive Differentiated Thyroid Cancer" @default.
- Q107973198 prefLabel "Study of Efficacy and Safety of Dabrafenib Plus Trametinib in Previously Treated Patients With Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E Mutation-positive Differentiated Thyroid Cancer" @default.
- Q107973198 P1132 Q107973198-A967C83F-7792-4A5B-8E07-22A2ED41E6CB @default.
- Q107973198 P1476 Q107973198-C885CEEC-42B9-4F79-AD30-B48B7F8636F5 @default.
- Q107973198 P2899 Q107973198-1F5C444B-7EE8-4F1E-A1F5-5F56FAA858B8 @default.
- Q107973198 P3098 Q107973198-126D6090-7329-4157-BFF7-BFC18B40C607 @default.
- Q107973198 P31 Q107973198-96E8F874-F3D8-4C77-BE97-CF2D15C6B13F @default.
- Q107973198 P4844 Q107973198-470CCF3E-1B42-4A13-963D-08964C11052A @default.
- Q107973198 P4844 Q107973198-D397A0E2-3A46-47A5-A454-FC0999B5530E @default.
- Q107973198 P580 Q107973198-C731B15B-E4A9-4FAC-8063-3EB56225D1A8 @default.
- Q107973198 P582 Q107973198-5EC18A53-A7CC-4D47-AA93-4E14D5D45F49 @default.
- Q107973198 P6099 Q107973198-2EC4AE8E-832C-41EF-87B3-9F2F882F4497 @default.
- Q107973198 P8005 Q107973198-7154CB60-32E4-45D9-A724-FD42469DD0E9 @default.
- Q107973198 P8363 Q107973198-2B148E50-5367-4B0E-A35D-6ABF116B8E6F @default.
- Q107973198 P859 Q107973198-FFC0C13D-E922-4D81-875D-F7C570E0E9C5 @default.
- Q107973198 P921 Q107973198-4C5E6965-104B-4E66-98E3-EAA0C86496A3 @default.
- Q107973198 P921 Q107973198-91C87BE1-36C8-422D-8981-1CF43AF9D082 @default.
- Q107973198 P1132 "+150" @default.
- Q107973198 P1476 "A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Dabrafenib Plus Trametinib in Previously Treated Patients With Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E Mutation-positive Differentiated Thyroid Cancer (DTC)" @default.
- Q107973198 P2899 "+18" @default.
- Q107973198 P3098 "NCT04940052" @default.
- Q107973198 P31 Q30612 @default.
- Q107973198 P4844 Q3011604 @default.
- Q107973198 P4844 Q7833138 @default.
- Q107973198 P580 "2021-10-01T00:00:00Z" @default.
- Q107973198 P582 "2024-02-19T00:00:00Z" @default.
- Q107973198 P6099 Q42824827 @default.
- Q107973198 P8005 Q76649614 @default.
- Q107973198 P8363 Q78089383 @default.
- Q107973198 P859 Q507154 @default.
- Q107973198 P921 Q3011604 @default.
- Q107973198 P921 Q7833138 @default.